
Rare Disease Care Gaps in NHS Labs Put Diagnosis at Risk, BMJ Finds
BMJ says NHS lab data-sharing gaps are delaying diagnosis and care for rare disease patients in England.
Health news on a wide range of other conditions, from rare diseases to newly recognised health risks.

BMJ says NHS lab data-sharing gaps are delaying diagnosis and care for rare disease patients in England.

NHS England says Martha’s Rule helplines helped flag more than 1,000 deterioration cases in 18 months.

UK regulators plan to withdraw Tavneos over unreliable trial data, intensifying scrutiny of vasculitis treatment evidence.

England will screen all newborns for spinal muscular atrophy, aiming to detect the rare disease earlier and improve outcomes.

UK regulators update guidance on AI scribes, highlighting patient safety, doctor accountability and the growing role of AI in healthcare.

NICE expands NHS access to new treatments for rare disease, cancer and diabetes, signaling broader innovation in care delivery.

Blood-based aging signatures may predict future risk of Alzheimer’s, ALS, lung cancer, type 2 diabetes and mortality.

England will screen all newborns for spinal muscular atrophy, expanding NHS early detection for a rare neuromuscular disease.

Nature reports new clues to idiopathic pulmonary fibrosis, highlighting a mouse study that points to a possible treatment path.

NICE approves givinostat for Duchenne muscular dystrophy, expanding NHS access for around 530 people in England.